Understanding the role of SORL1 in Alzheimer's disease
Molecular analysis of SORL1 function and dysfunction in Alzheimer's disease
This study is looking at how a protein called SORL1 might play a role in the development of Alzheimer's disease, with the hope that understanding this could lead to new treatments for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10825622 on NIH RePORTER |
What this research studies
This research investigates how the SORL1 protein affects the development and progression of Alzheimer's disease (AD). By analyzing the molecular mechanisms of SORL1, the study aims to uncover how disruptions in protein trafficking contribute to neurodegeneration in AD. Patients may benefit from insights gained into the genetic factors and pathways involved in AD, potentially leading to new therapeutic strategies. The research employs advanced molecular biology techniques to explore the relationship between SORL1 mutations and AD pathology.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of Alzheimer's disease or those diagnosed with late-onset Alzheimer's.
Not a fit: Patients with early-onset Alzheimer's disease unrelated to SORL1 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new interventions that target the underlying mechanisms of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of genetic factors in Alzheimer's disease, making this approach a continuation of established findings.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Li, Lian — Emory University
- Study coordinator: Li, Lian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.